All News
Lento Bio Announces Official Collaboration With Florida State University and Expansion of Advisory Board
POTSDAM, NY, USA, February 7, 2023/EINPresswire.com- Lento Bio, an early-stage pharmaceutical research company developing novel small molecule drugs for presbyopia, is proud to announce two
Lento Bio Raises $680,000 In Oversubscribed Seed Round Led by Ichor Life Sciences
POTSDAM, NY / September 6, 2022 / Lento Bio, Inc., a preclinical pharmaceutical company developing small-molecule therapeutics to restore ocular lens flexibility and near-vision in presbyopia
Lento Bio Appoints Two Ichor Life Sciences Executives as Members of The Board of Directors and Scientific Advisors
Potsdam, N.Y. – Lento Bio, Inc., a preclinical pharmaceutical company developing therapeutics to target molecular damage driving age-related disease, announced today it appointed Dr. Kelsey
Lento Bio, An Ichor Life Sciences Portfolio Company, Launches With Aims to Develop Anti-Glycation Drugs for Presbyopia and Diseases of Aging
Potsdam, N.Y. –. Lento Bio, Inc., a preclinical pharmaceutical company focused on developing small-molecule therapeutics to target molecular damage driving age-related disease, announced its launch